CIK: 0002056786 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Jan 23, 2026
Total Value ($000): $264,259 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAVN | NAVAN INC | 200,000 | $3,416 | 1.3% | $15.89 | 0.0% | CL A | 639193101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FIGR | FIGURE TECHNOLOGY SOLUTIO | 680,000 | $24,732 | 9.4% | $38.84 | +3.0% | — | 349381103 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,196,200 | $174,927 | 66.2% | $40.59 | +61.5% | COM | 76155X100 |
| SAIL | SAILPOINT INC | 3,000,000 | $60,690 | 23.0% | $21.79 | -4.3% | COM | 78781J109 |
| LINE | LINEAGE INC | 600,000 | $21,000 | 7.9% | $58.63 | — | COM | 53566V106 |
| RVMDW | REVOLUTION MEDICINES INC | 450,000 | $423 | 0.2% | $0.26 | — | *W EXP 12/17/202 | 76155X118 |
| NMRA | NEUMORA THERAPEUTICS INC. | 2,124,143 | $3,802 | 1.4% | $1.71 | +27.9% | COM | 640979100 |